The Joint Corp. (JYNT)
After hours:
| Previous close | 12.79 |
| Open | 12.77 |
| Bid | 12.83 x 100 |
| Ask | 12.92 x 200 |
| Day's range | 12.54 - 13.03 |
| 52-week range | 7.31 - 16.43 |
| Volume | |
| Avg. volume | 90,724 |
| Market cap | 192.073M |
| Beta (5Y monthly) | 1.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.66 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.19 |
ZacksThe Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates
The Joint (JYNT) delivered earnings and revenue surprises of 300% and 1.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GuruFocus.comThe Joint Corp (JYNT) Q1 2024 Earnings: Revenue Grows, Surpassing Analyst Projections
A Detailed Look at The Joint Corp's First Quarter Financial Performance
GlobeNewswireThe Joint Corp. Reports First Quarter 2024 Financial Results
- Grew Q1 2024 Revenue 5%, System-wide Sales 9%, and System-wide Comp Sales 3% vs. Q1 2023 - - Opened 23 Franchised Clinics, Increasing Clinic Count to 954 at March 31, 2024 - - Sold 15 Franchise Licenses, Tripling Sales Compared to Q4 2023 - SCOTTSDALE, Ariz., May 02, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter ended March 31, 2024. Financial Highlights: Q1 2024 Comp
